endometrial carcinoma

Follitropin is possibly associated with increased risk of endometrial carcinoma.

Progesterone and estrogen hormone receptors have been identified in endometrial carcinoma tissues.

Sixty percent of patients present with abnormal uterine bleeding, and 20% have endometrial carcinoma.

ULM has also been reported associated to endometrial carcinoma and breast cancer.

Some authorities have proposed that endometrial carcinomas be classified into two pathogenetic groups:

Endometrial carcinoma is the third most common cause of gynecologic cancer death (behind ovarian and cervical cancer).

Published recommendations for screening certain groups of women at high risk for endometrial carcinoma are based on opinion regarding presumptive benefit.

The microscopic differential diagnosis includes endometrial carcinoma and endocervical adenocarcinoma.

Endometrial biopsy is cheap, safe, quick, easy, and useful for diagnosing endometrial carcinoma.

Uterus - tamoxifen may increase endometrial carcinoma risk, but raloxifene and femarelle do not.

Endometrial carcinomas originate from cells in the glands of the endometrium (uterine lining).

There is an association with endometriosis and concurrent primary endometrial carcinoma (endometrial cancer).

Endometrial carcinoma is surgically staged using the FIGO cancer staging system.

Post Operative Radiation Therapy in Endometrial Carcinoma.

Lentz SS: Advanced and recurrent endometrial carcinoma: hormonal therapy.

Finally, malignant mixed Müllerian tumors, a type of carcinosarcoma, are staged similarly to endometrial carcinomas.

Most uterine cancers arise in the endometrium and are called endometrial cancer or endometrial carcinoma.

Over-expression is also known to occur in ovarian, stomach, and aggressive forms of uterine cancer, such as uterine serous endometrial carcinoma.

As with endometrial carcinomas, the prognosis is influenced by the grade and type of the adenocarcinoma, being poorest with serous differentiation.

The vast majority of malignancies of the uterine body are endometrial carcinomas - only about 4% will be uterine sarcomas.

In addition, there is a presdisposition to breast carcinoma, follicular carcinoma of the thyroid, and endometrial carcinoma.

Women who still have a uterus need to take progesterone in addition to estrogen to protect against the development of endometrial hyperplasia and endometrial carcinoma.

Endometrial carcinoma (cancer of the uterine lining) usually causes irregular bleeding, rather than the cyclical pattern of menorrhagia.

Neoplastic diseases of the uterus: Endometrial hyperplasia, endometrial carcinoma, sarcoma: Diagnosis and management.

Kauppila A, Friberg LG: Hormonal and cytotoxic chemotherapy for endometrial carcinoma.